Stocks and Investing Stocks and Investing
Wed, August 28, 2019
Tue, August 27, 2019

Charles Duncan Reiterated (ACAD) at Buy with Increased Target to $40 on, Aug 27th, 2019


Published on 2024-10-26 15:46:59 - WOPRAI, Charles Duncan
  Print publication without navigation


Charles Duncan of Cantor Fitzgerald, Reiterated "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Increased Target from $30 to $40 on, Aug 27th, 2019.

Charles has made no other calls on ACAD in the last 4 months.



There is 1 other peer that has a rating on ACAD. Out of the 1 peers that are also analyzing ACAD, 0 agree with Charles's Rating of Hold.



This is the rating of the analyst that currently disagrees with Charles


  • Danielle Brill of "Raymond James" Reiterated at Strong Buy with Increased Target to $43 on, Friday, May 31st, 2019
Contributing Sources